S 5316
117th Congress
Senate
Health
Administrative law and regulatory procedures
Advisory bodies
Congressional oversight
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Food and Drug Administration (FDA)
Food supply, safety, and labeling
Government information and archives
Research administration and funding
Federal Clarity for Kratom Consumers Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 20, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 20, 2022
Introduced in Senate
Plain-English summary
Federal Clarity for Kratom Consumers Act
This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1
Cosponsors
1